JACK VASSAR: Open Payments
NPI 1750661633 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 19 payments from 11 companies in 2025. Trend: 2023 $238 · 2024 $283 · 2025 $574
Food & beverage: $474Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $118 |
| SEAGEN INC. | 1 | $100 |
| COLOPLAST CORP | 3 | $83 |
| ABC Home Medical Supply, Inc. | 2 | $72 |
| UROGEN PHARMA, INC. | 2 | $55 |
| Gilead Sciences, Inc. | 2 | $45 |
| Medtronic, Inc. | 1 | $23 |
| IMMUNITYBIO, INC. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| PFIZER INC. | 1 | $21 |
Products named: GEMTESA, JELMYTO, SpeediCath, Titan, INTERSTIM, ANKTIVA, KEYTRUDA, XTANDI.
Industry payments across NY — which companies pay providers there.
